Venture debt is a tourniquet: it stops the bleed, it is not new blood

Venture debt is a tourniquet. The same tool saves a life or takes a limb, and the difference is when you tie it on and when you take it off.

A tourniquet does one thing. It applies pressure, it stops the flow of blood to a limb, and it can buy you time until real help can arrive. It is first aid, not a cure. You do not walk around with one on. You tie it tightly when you are bleeding out, and you take it off the second the wound is closed, because the same pressure that saved the limb will damage it if you leave it there too long.

Now take that idea again as a founder, with cash where the blood is.

Venture debt is a tourniquet. It buys time by stopping the bleed. It is not new blood, and left on too long it costs you the limb.

The rest of this piece walks through why that is true.

What venture debt actually is

Venture debt is a loan made to a startup that has already raised equity. You borrow money, you pay it back with interest, and your ownership is left where it was. It is the best-known form of non-dilutive financing, which just means capital that does not cost you a part of the company. There are no new shares and no new owner taking a seat.

That is the appeal in one line. It is also where founders get themselves wounded.

Because non-dilutive does not mean free, and it certainly does not mean safe. A tourniquet is also non-dilutive. It does not add a single unit of blood to your body. It just stops you from losing more, for a while, at a real cost to the tissue below it. Venture debt works the same way. It does not put new revenue into the company. It stops the cash from running out long enough for something else to close the actual wound.

So before all else, get the mental model straight. Debt is pressure on the bleed, and pressure is not the same as new blood in the body.

Stopping the bleed is not the same as healing

A startup that is burning more cash than it can earn is bleeding. The cash goes out, less comes back, and the runway falls until there is none left. That is the wound.

Venture debt does not close that wound. It can give you a little time. The money comes in, the runway can extend, the immediate loss is controlled. Founders feel that and take it as recovery. It is not. The vital signs look stable because you tied something tightly, not because the bleeding stopped on its own.

The distinction is this. A tourniquet is the right call when help is on the way, when there is a specific reason the bleeding will actually be handled soon, such as a real milestone, a revenue floor you can see, or a round that closes because the next investor is already interested. You are binding the wound only long enough to reach the thing that closes it.

But tie a tourniquet onto a wound that no help is coming to close, and you have not saved the limb. You have just put a clear date on losing it.

Why the limb dies if you leave it on too long

Founders tend to miss this, because the early comfort feels so good.

A tourniquet left on past its window does not just stop being helpful. It does damage. Stop the flow of blood to a limb for too long and the tissue begins to die from the very pressure that saved it. Surgeons time it for a reason. The tool that controlled the bleeding becomes the thing that costs you the limb.

Venture debt has two places where it does that to a company, and the more dangerous one is not the interest rate that lenders show you up front.

The first is warrants. A lender usually takes the right to buy a small amount of equity at a fixed price later, which lives within your “non-dilutive” loan. It is small, far less than a full round, but it means no dilution at all is rarely true. Price it in.

The second is the one that takes limbs. Covenants. The covenants are the conditions you promise to keep while the loan is outstanding: hold a minimum cash balance, hit a revenue floor, keep your burn under a ceiling, raise the next round by a set date. Break one and you have an event of default, even if you have never been late on a payment. The lender can then demand immediate repayment of the full balance, take control of pledged accounts, or force you into a negotiation from a position of strength that is the lender’s and not the company’s. A single breach can turn a healthy-looking company into a fire sale in one quarter.

That is the limb dying. The same loan that stopped your bleed in March can amputate the company by September if you left it on too long and break the covenants you should never have agreed to.

A common rule of thumb sizes venture debt at roughly a quarter to a third of your most recent equity round.

Actually, let me correct one thing I said. The rule of thumb is not about how much pressure you can take. It is about how much your investors already believe in you. Venture debt is underwritten in part against your existing investors continuing to fund you. A company that has not raised venture equity generally cannot get venture debt at all. The hand of your investors is the thing holding the tourniquet on, which is the very reason it turns dangerous the second that hand is in question.

When to tie it on, and when to take it off

I keep coming back to one thing, and you should too. Can you see the cash that takes this tourniquet back off, or are you only hoping?

Tie it on when there is real help on the way. You have steady, regular revenue that covers the payments with a little room to give. Maybe you are binding the wound to reach a specific milestone that raises your value, such as a product launch, a revenue floor, or a contract that closes. Maybe you are extending runway between rounds so you reach the next raise from strength and a higher valuation instead of out of cash and out of leverage. Or you are financing receivables, borrowing against money customers already owe you, which is about the lowest-risk thing there is to lend against.

Take it off, or never tie it on at all, in the cases that turn all of that around. Avoid it before you have revenue, since you cannot make the payments and you cannot meet the covenants. Avoid it to fund losses you cannot close, where the loan only papers over a business that bleeds on every unit at scale. And avoid it when there is no clear path to repay or to stay within the covenants, when the loan is only a hope that the next round will come and rescue you. In those cases it is not first aid at all, just a tourniquet on a wound that no help is coming to close.

A founder I know tied one on at the right time last year. She had a contract closing in five months, regular revenue under it, and a short gap to bridge. She took roughly a quarter of her last round in venture debt, hit the milestone, raised at a higher valuation, and paid the loan down. Pressure on, wound closed, tourniquet off. That is the full point of the tool.

The 2023 banking stress made this real for a lot of people. When credit tightened and a major lender failed, debt-heavy companies learned that capital access goes fast and covenants turn hard when everyone demands repayment at once. The lesson was not that venture debt is bad, but that a tourniquet is only as safe as the help you are counting on to arrive, and that arrival was never within your control.

Frequently asked questions

What is venture debt in simple terms?

Venture debt is a loan made to a startup that has already raised equity from venture investors. You get cash now and pay it back with interest over time, usually with a small warrant attached and a set of covenants you have to keep. It lets you raise money without selling more ownership, which is why we call it non-dilutive financing. Think of it as first aid for a cash bleed, not new revenue.

Is venture debt really non-dilutive?

Mostly, with an asterisk. The loan itself does not sell equity, so the bulk of it is non-dilutive. But lenders often take warrants, the right to buy a small amount of stock later, so there is a thin layer of dilution within the deal. It is far less than an equity round, but it is not literally zero, so non-dilutive should never be read as free.

What happens if you breach your covenants?

A breach is an event of default, even if every payment is current. Depending on the terms, the lender can demand immediate repayment of the full balance, take control of pledged accounts, or force you into a negotiation from a position of strength. A single breach can take a company from healthy-looking to distress in one quarter. That is the tourniquet taking the limb, which is why you size debt to stay well within the covenants, not right at the limit.

When should a founder choose venture debt over equity?

When you have steady revenue to service it and a specific milestone or next round it can bridge you to. Debt is cheaper than equity in those cases because you rent the money instead of selling the ownership. Choose equity when the future is uncertain, you are pre-revenue, or you need capital you are not bound to repay if things go bad. Bind the tourniquet on only when you can see the help on the way.

The core point on venture debt: pressure buys time, it does not refill the tank

Venture debt is a tourniquet. For a company with revenue you can see and a milestone you can name, it is the right tool at the right time: it stops the bleed, holds the pressure, and comes off when the wound closes. For a company losing money with no path out, the same loan is just a clear date set on losing the limb, plus interest. It is the same tool in both cases, and what changes the outcome is when you tie it on and when you take it off.

You should know where the money is going. Because you cannot tell whether you can take this tourniquet back off if you cannot see your cash, your runway, and your real path to the next round. That is what CX Cash is built to show you. Sign up free, grab our investor update template and cap table and dilution calculator, and run the numbers before a lender can run them for you. Then send this to the founder who is about to tie one on and never planned how to take it off.